You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 223 No. 9, February 26, 1973 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antibody Responses in Viral Hepatitis, Type B

Lewellys F. Barker, MD; Michael R. Peterson, MD; N. Raphael Shulman, MD; Roderick Murray, MD

JAMA. 1973;223(9):1005-1008.


Abstract

Most individuals with viral hepatitis, type B, acquire a serum antigen (hepatitis-B antigen [HB Ag])1 at some time during the incubation period or the acute phase of the disease. Serial sera from 88 patients with viral hepatitis, type B, were examined for antibodies against HB Ag (anti-HB Ag) by passive hemagglutination (PHA) and radioimmunoassay (RIA) methods. Seventy individuals (79.5%) were found to develop serum anti-HB Ag at some time after exposure. Overt occurrences of hepatitis were usually followed by primary-type anti-HB Ag responses. However, early- or secondary-type anti-HB Ag responses were seen in 17 individuals who subsequently developed clinical hepatitis. Most individuals who were resistant to infection after parenteral exposure to materials known to transmit hepatitis had secondary antibody responses. We conclude that primary antibody responses to HB Ag are common after viral hepatitis, type B, and that protective immunity frequently but not invariably follows early exposure to hepatitis-B virus.



Author Affiliations

From the Division of Biologics Standards (Drs. Barker, Peterson, and Murray) and the National Institute of Arthritis and Metabolic Diseases (Dr. Shulman), National Institutes of Health, Bethesda, Md. Dr. Peterson is now with Langley porter Neuropsychiatric Institute, University of California Medical Center, San Francisco. Dr. Barker is now with the Bureau of Biologics, Food and Drug Administration, Rockville, Md. Dr. Murray is now with the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.


Footnotes

Reprint requests to 5600 Fishers Lane, Rockville, Md 20852.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hepatitis B Surface Antigen (HBsAg) and Antibody to HBsAg: Prevalence in Homosexual and Heterosexual Men
Dietzman et al.
JAMA 1977;238:2625-2626.
ABSTRACT  

Transmission of Non-A, Non-B Hepatitis
HOOFNAGLE et al.
ANN INTERN MED 1977;87:14-20.
ABSTRACT  

Absence of Complete Homologous Immunity in Hepatitis B Infection After Massive Exposure
TREPO and PRINCE
ANN INTERN MED 1976;85:427-430.
ABSTRACT  

Dental Infection With Hepatitis B
Williams et al.
JAMA 1975;232:1231-1233.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.